Claritev Corp. (CTEV)
29.69
-0.37
(-1.23%)
USD |
NYSE |
Jan 16, 10:08
Claritev EPS Diluted (Quarterly): -4.232 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Spok Holdings, Inc. | 0.1523 |
| DarioHealth Corp. | -3.052 |
| National Research Corp. | 0.1805 |
| GoodRx Holdings, Inc. | 0.0032 |
| Certara, Inc. | 0.0095 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -69.75M |
| Revenue (Quarterly) | 245.96M |
| Total Expenses (Quarterly) | 315.71M |
| Enterprise Value | 5.099B |
| Gross Profit Margin (Quarterly) | 29.26% |
| Profit Margin (Quarterly) | -28.36% |
| Earnings Yield | -70.54% |
| Operating Earnings Yield | 10.46% |
| Normalized Earnings Yield | -51.87 |